NovoCure Limited
15.63USD
-1.2200 (-7.24%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 184 | 174 | 174 | 167 | 159 | 155 | 161 | 155 |
| Cost of Revenue | 41 | 39 | 42 | 45 | 41 | 39 | 33 | 35 |
| Gross Profit | 142 | 135 | 132 | 122 | 117 | 116 | 128 | 120 |
| Operating Income | -11 | -67 | -40 | -36 | -40 | -38 | -63 | -32 |
| Net Income | -16 | -71 | -24 | -37 | -40 | -34 | -66 | -31 |
| EPS (Diluted) | $-0.13 | $-0.62 | $-0.22 | $-0.33 | $-0.36 | $-0.31 | $-0.61 | $-0.28 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)